Gilbert & Cook, Inc. Amgen Inc Transaction History

Gilbert & Cook, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 14, 2021	SELL	$221.91 - $258.6 $280,494 - $326,870	-1,264 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $43,708 - $52,049	202 Added 19.02%	1,264 $292,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $20,649 - $22,963	88 Added 9.03%	1,062 $270,000
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $192,666 - $236,428	974 New	974 $230,000
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $162,011 - $214,871	-889 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$189.21 - $243.2 $168,207 - $216,204	889 New	889 $214,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Gilbert & Cook, Inc., based on Form 13F filings with the SEC.

Stay updated on Gilbert & Cook, Inc. with notifications on news.